Microplastics Safety Act
- Bill Number
- H.R. 4486
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-07-17: Referred to the House Committee on Energy and Commerce.
- Last Updated
- 2026-06-24T08:09:48Z
AI-Generated Summary
Purpose
The Microplastics Safety Act (H.R. 4486) aims to assess the risks posed by microplastics—tiny plastic particles smaller than 5 millimeters—to human health through everyday sources like food and water. It directs the U.S. Food and Drug Administration (FDA) to investigate these risks and provide Congress with evidence-based recommendations to inform future protections.
Key Provisions
- Mandated Study: The Secretary of Health and Human Services, through the FDA Commissioner, must conduct a comprehensive study on human exposure to microplastics in food and water. This includes:
- Identifying primary ways people encounter microplastics (e.g., through ingestion via contaminated sources).
- Evaluating health effects on specific areas, such as:
- Children's health (e.g., developmental impacts).
- The endocrine system (hormone-regulating body processes).
- Cancer risks.
- Chronic illnesses (long-term conditions like respiratory or digestive issues).
- Reproductive health (fertility and pregnancy outcomes).
- Covering any other relevant health concerns deemed important by the FDA.
- Required Report: Within one year of the bill's enactment, the FDA must submit a detailed report to Congress summarizing:
- The study's findings and conclusions.
- Recommendations for new laws or FDA actions to mitigate health risks from microplastics.
Significant Changes to Existing Law
This bill introduces a new federal requirement for the FDA to specifically study and report on microplastics' health impacts, which is not addressed in current U.S. food and water safety laws like the Federal Food, Drug, and Cosmetic Act. It expands the FDA's research obligations without altering existing regulations, potentially laying groundwork for future standards on plastic contaminants.
Potential Impacts
- On Government Agencies: The FDA will need to allocate resources for research, data collection, and reporting, which could strain budgets but enhance its role in environmental health monitoring. Congress may use the report to guide oversight or new legislation.
- On Citizens: Increased awareness and potential future regulations could lead to safer food and water supplies, benefiting public health—especially vulnerable groups like children and those with chronic conditions—by reducing exposure to harmful plastics.
- On International Relations: Minimal direct impact, though findings could influence U.S. participation in global efforts (e.g., UN environmental treaties) to curb plastic pollution, potentially pressuring international trade partners to adopt similar standards.
Main Stakeholders Affected
- Government Entities: FDA (leads the study), Department of Health and Human Services (oversight), and Congress (receives report and may act on recommendations).
- Citizens and Public Health Groups: Individuals exposed to microplastics via diet and drinking water; advocacy organizations focused on environmental and consumer safety (e.g., those addressing pollution or food purity).
- Industry and Businesses: Food and beverage producers, water utilities, and plastics manufacturers, who may face future compliance costs if recommendations lead to stricter contaminant limits.
- Researchers and Scientists: Benefits from funded studies, enabling further work on emerging pollutants.
Notable Legal, Constitutional, or Political Implications
- Legal: Establishes a clear, time-bound mandate enforceable through congressional oversight, without granting new regulatory powers to the FDA—any actions would require follow-up legislation.
- Constitutional: Aligns with Congress's authority under the Commerce Clause to regulate interstate commerce, including food and water safety, and promote general welfare by addressing public health threats.
- Political: Bipartisan introduction (by Reps. Bynum and Steube) highlights growing consensus on environmental health issues; the bill could spark debate on balancing innovation in plastics with precautionary health measures, potentially influencing election-year priorities on pollution and consumer protection.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. Bynum, Janelle S. [D-OR-5]
Cosponsors (16)
Rep. Steube, W. Gregory [R-FL-17], Rep. Lawler, Michael [R-NY-17], Rep. Krishnamoorthi, Raja [D-IL-8], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Vargas, Juan [D-CA-52], Rep. Dingell, Debbie [D-MI-6], Rep. Bilirakis, Gus M. [R-FL-12], Rep. Kim, Young [R-CA-40], Rep. Mackenzie, Ryan [R-PA-7], Rep. LaLota, Nick [R-NY-1], Rep. Johnson, Henry C. "Hank" [D-GA-4], Rescom. Hernández, Pablo Jose [D-PR-At Large], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Brownley, Julia [D-CA-26], Rep. Haridopolos, Mike [R-FL-8], Rep. Vindman, Eugene Simon [D-VA-7]
Recent Actions
- 2025-07-17: Referred to the House Committee on Energy and Commerce.
- 2025-07-17: Introduced in House
- 2025-07-17: Introduced in House
Bill Versions
- Microplastics Safety Act — issued 2025-07-17 — PDF (3 pages)